Compositions and methods for inhibiting expression of RRM2 genes Grant US-11920134-B2 United States of America 05 Mar 2024
Carbohydrate conjugates as delivery agents for oligonucleotides Grant US-11666653-B2 United States of America 06 Jun 2023
RNAi agents for hepatitis B virus infection Grant US-11590156-B2 United States of America 28 Feb 2023
RNAi therapy for hepatitis B virus infection Grant US-11534453-B2 United States of America 27 Dec 2022
RNAi agents for Hepatitis B virus infection Grant US-11517584-B2 United States of America 06 Dec 2022
Hepatitis B virus (HBV) dsRNA agent compositions and methods of use thereof Grant US-11492623-B2 United States of America 08 Nov 2022
Methods for the treatment of subjects having a hepatitis b virus (HBV) infection Grant US-11324820-B2 United States of America 10 May 2022
Carbohydrate conjugates as delivery agents for oligonucleotides Grant US-11110174-B2 United States of America 07 Sep 2021
Hepatitis B virus (HBV) iRNA compositions and methods of use thereof Grant US-11060091-B2 United States of America 13 Jul 2021
Compositions and methods for inhibiting gene expression of hepatitis B virus Grant US-RE48345-E1 United States of America 08 Dec 2020
RNAi therapy for hepatitis B virus infection Grant US-10806750-B2 United States of America 20 Oct 2020
Carbohydrate conjugates as delivery agents for oligonucleotides Grant US-10806791-B2 United States of America 20 Oct 2020
Compositions and methods for inhibiting expression of RRM2 genes Grant US-10619160-B2 United States of America 14 Apr 2020
Organic compounds to treat hepatitis B virus Application US-10519446-B2 United States of America 31 Dec 2019
Hepatitis B virus (HBV) iRNA compositions and methods of use thereof Grant US-10513703-B2 United States of America 24 Dec 2019
3′end caps for RNAi agents for use in RNA interference Grant US-10227588-B2 United States of America 12 Mar 2019
RNAi Therapy for Hepatitis B Virus Infection Grant US-10130651-B2 United States of America 20 Nov 2018
Formats for organic compounds for use in RNA interference Application US-9988627-B2 United States of America 05 Jun 2018
Compositions and methods for inhibiting expression of RRM2 genes Application US-9938531-B2 United States of America 10 Apr 2018
Carbohydrate conjugates as delivery agents for oligonucleotides Grant US-9867882-B2 United States of America 16 Jan 2018
Carbohydrate conjugates as delivery agents for oligonucleotides Grant US-9370581-B2 United States of America 21 Jun 2016
Carbohydrate conjugates as delivery agents for oligonucleotides Grant US-9370582-B2 United States of America 21 Jun 2016
Carbohydrate conjugates as delivery agents for oligonucleotides Grant US-9352048-B2 United States of America 31 May 2016
Biologically active molecules, particularly based on PNA and siRNA, method for the cell-spe… Application US-9347060-B2 United States of America 24 May 2016
Compositions and methods for inhibiting expression of RRM2 genes Grant US-8946176-B2 United States of America 03 Feb 2015
Carbohydrate conjugates as delivery agents for oligonucleotides Grant US-8828956-B2 United States of America 09 Sep 2014
METHOD FOR THE TARGETED KILLING OF CELLS BY NUCLEOTIDE MOLECULES DIRECTED FOR MRNA BINDING… Application WO-2014131773-A2 World Intellectual Property Organisation (WIPO) 04 Sep 2014
Compositions and methods for inhibiting gene expression of hepatitis B virus Grant US-8809293-B2 United States of America 19 Aug 2014
COMPOSITIONS AND METHODS FOR FUNCTIONAL NUCLEIC ACID DELIVERY Application WO-2014093688-A1 World Intellectual Property Organisation (WIPO) 19 Jun 2014
NEW CELL-SPECIFICALLY ACTIVE NUCLEOTIDE MOLECULES AND APPLICATION KIT FOR THE APPLICATION… Application WO-2014076213-A1 World Intellectual Property Organisation (WIPO) 22 May 2014
POLYMERIC SYSTEMS CONTAINING INTRACELLULAR RELEASABLE DISULFIDE LINKER FOR THE DELIVERY… Application EP-2288261-A4 European Patent Office 25 Sep 2013
Carbohydrate conjugates as delivery agents for oligonucleotides Grant US-8450467-B2 United States of America 28 May 2013
TRANSFERRIN/TRANSFERRIN RECEPTOR-MEDIATED siRNA DELIVERY Application WO-2012161677-A1 World Intellectual Property Organisation (WIPO) 29 Nov 2012
BIOLOGICALLY ACTIVE NUCLEOTIDE MOLECULES FOR SELECTIVELY KILLING OFF CELLS, USE THEREOF… Application WO-2012098234-A1 World Intellectual Property Organisation (WIPO) 26 Jul 2012
BIOLOGICALLY ACTIVE MOLECULES THAT ARE BASED ON SIRNA AND THAT CAN BE ACTIVATED IN A CELL-S… Application WO-2011150921-A2 World Intellectual Property Organisation (WIPO) 08 Dec 2011
BIOLOGICALLY ACTIVE MOLECULES FOR INFLUENCING VIRUS-, BACTERIA-, PARASITE-INFECTED CELLS… Application WO-2011085720-A1 World Intellectual Property Organisation (WIPO) 21 Jul 2011
POLYMERIC SYSTEMS CONTAINING INTRACELLULAR RELEASABLE DISULFIDE LINKER FOR THE DELIVERY… Application EP-2288261-A2 European Patent Office 02 Mar 2011
CELL-SPECIFICALLY EFFECTIVE MOLECULES ON THE BASIS OF SIRNA AND APPLICATION KITS FOR THE… Application WO-2010102615-A1 World Intellectual Property Organisation (WIPO) 16 Sep 2010
RECEPTOR TARGETED OLIGONUCLEOTIDES Application WO-2009045536-A2 World Intellectual Property Organisation (WIPO) 09 Apr 2009
BIOLOGICALLY ACTIVE MOLECULES, PARTICULARLY BASED ON PNA AND SIRNA, METHOD FOR THE CELL-SPE… Application WO-2008098569-A2 World Intellectual Property Organisation (WIPO) 21 Aug 2008